For citations:
Dokukina T.V., Makhrov M.V., Gaidukevich I.V., Gilep A.A., Golubeva T.S., Khlebokazov F.P., Misyuk N.N., Korolevich P.P. OPPORTUNITIES TO OPTIMIZE ANTIEPILEPTIC THERAPY WITH USE OF PHARMACOGENETIC BIOMARKERS. Epilepsy and paroxysmal conditions. 2015;7(4):22-28. (In Russ.)

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.